Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Cullinan Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 174 | 2 | 183 | +11 |
| Shares | 65.6M | 30.7K | 71.6M | +6.12M (+9.3%) |
| Value | $931.0M | $436.5K | $1.30B | +$373.8M (+40.2%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (31)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (20)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Nextech Invest, Ltd. | 1,141,145 | $16.2M |
| Deerfield Management Company, L.P. (Series C) | 386,169 | $5.49M |
| OrbiMed Advisors LLC | 243,006 | $3.45M |
| Schroder Investment Management Group | 173,740 | $2.33M |
| Cinctive Capital Management LP | 94,444 | $1.34M |
| Superstring Capital Management LP | 59,484 | $845.3K |
| ADAR1 Capital Management, LLC | 50,000 | $710.5K |
| Gsa Capital Partners LLP | 43,339 | $616.0K |
| HRT Financial LP | 38,586 | $548.0K |
| Voleon Capital Management LP | 24,092 | $342.3K |
| Brevan Howard Capital Management LP | 24,078 | $342.1K |
| Jane Street Group, LLC | 22,812 | $324.2K |
| Quadrature Capital Ltd | 10,577 | $150.3K |
| ProShare Advisors LLC | 10,465 | $148.7K |
| Seven Fleet Capital Management LP | 1,844 | $26.2K |
| Public Employees Retirement Association of Colorado | 1,150 | $16.0K |
| MAI Capital Management | 938 | $13.3K |
| Quadrant Capital Group LLC | 761 | $10.8K |
| Wealth Preservation Advisors, LLC | 84 | $1.19K |
| Root Financial Partners, LLC | 62 | $881 |
Not filed for Q2 2026 yet (2)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 18,528 | $263.2K |
| CWM, LLC | 12,196 | $173.3K |